Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies

Chen Ling,1 Xiaobo Wang,1 Yan Shen2 1School of Pharmacy, China Pharmaceutical University, Nanjing 211100, People’s Republic of China; 2Department of Pharmaceutics, China Pharmaceutical University, Nanjing 211100, People’s Republic of ChinaCorrespondence: Yan Shen Tel +86 (025) 83...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ling C, Wang X, Shen Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/7124e64d634b47ee957cb78f1773e981
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7124e64d634b47ee957cb78f1773e981
record_format dspace
spelling oai:doaj.org-article:7124e64d634b47ee957cb78f1773e9812021-12-02T13:44:01ZAdvances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies1178-2013https://doaj.org/article/7124e64d634b47ee957cb78f1773e9812021-01-01T00:00:00Zhttps://www.dovepress.com/advances-in-hollow-inorganic-nanomedicines-for-photothermal-based-ther-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Chen Ling,1 Xiaobo Wang,1 Yan Shen2 1School of Pharmacy, China Pharmaceutical University, Nanjing 211100, People’s Republic of China; 2Department of Pharmaceutics, China Pharmaceutical University, Nanjing 211100, People’s Republic of ChinaCorrespondence: Yan Shen Tel +86 (025) 83271305Email shenyan@cpu.edu.cnAbstract: Nanotechnology has prompted the development of hollow inorganic nanomedicine. These medicines are now widely investigated as photothermal-based therapies for various diseases due to their high loading capacity, tuneable wavelength, relatively small size and low density. We begin this review with a brief introduction, followed by a summary of the development of imaging-guided photothermal therapy (PTT) for cancer treatment during the last three years (from 2017 to 2020). We then introduce the antibacterial effects of these medicines on some bacterial infections, in which the pathogenic bacteria can be killed by mild photothermal effects, ions and antibiotic release. Other diseases can also be treated using hollow inorganic photothermal agents. Specifically, we discuss the use of PTT for treating Alzheimer’s disease, obesity and endometriosis. Finally, we share our perspectives on the current challenges and future prospects of using hollow inorganic materials in clinical PTT for various diseases.Keywords: hollow inorganic nanomedicine, photothermal therapy, diseasesLing CWang XShen YDove Medical Pressarticlehollow inorganic nanomedicinephotothermal therapydiseasesMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 493-513 (2021)
institution DOAJ
collection DOAJ
language EN
topic hollow inorganic nanomedicine
photothermal therapy
diseases
Medicine (General)
R5-920
spellingShingle hollow inorganic nanomedicine
photothermal therapy
diseases
Medicine (General)
R5-920
Ling C
Wang X
Shen Y
Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies
description Chen Ling,1 Xiaobo Wang,1 Yan Shen2 1School of Pharmacy, China Pharmaceutical University, Nanjing 211100, People’s Republic of China; 2Department of Pharmaceutics, China Pharmaceutical University, Nanjing 211100, People’s Republic of ChinaCorrespondence: Yan Shen Tel +86 (025) 83271305Email shenyan@cpu.edu.cnAbstract: Nanotechnology has prompted the development of hollow inorganic nanomedicine. These medicines are now widely investigated as photothermal-based therapies for various diseases due to their high loading capacity, tuneable wavelength, relatively small size and low density. We begin this review with a brief introduction, followed by a summary of the development of imaging-guided photothermal therapy (PTT) for cancer treatment during the last three years (from 2017 to 2020). We then introduce the antibacterial effects of these medicines on some bacterial infections, in which the pathogenic bacteria can be killed by mild photothermal effects, ions and antibiotic release. Other diseases can also be treated using hollow inorganic photothermal agents. Specifically, we discuss the use of PTT for treating Alzheimer’s disease, obesity and endometriosis. Finally, we share our perspectives on the current challenges and future prospects of using hollow inorganic materials in clinical PTT for various diseases.Keywords: hollow inorganic nanomedicine, photothermal therapy, diseases
format article
author Ling C
Wang X
Shen Y
author_facet Ling C
Wang X
Shen Y
author_sort Ling C
title Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies
title_short Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies
title_full Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies
title_fullStr Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies
title_full_unstemmed Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies
title_sort advances in hollow inorganic nanomedicines for photothermal-based therapies
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/7124e64d634b47ee957cb78f1773e981
work_keys_str_mv AT lingc advancesinhollowinorganicnanomedicinesforphotothermalbasedtherapies
AT wangx advancesinhollowinorganicnanomedicinesforphotothermalbasedtherapies
AT sheny advancesinhollowinorganicnanomedicinesforphotothermalbasedtherapies
_version_ 1718392501490941952